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Summary
 
We have recently shown that monomeric bacterial LPS is rapidly delivered from the plasma
membrane to an intracellular site and that agents that block vesicular transport block responses
of neutrophils to lipopolysaccharide (LPS) (Detmers, P.A., N. Thiéblemont, T. Vasselon, R.
Pironkova, D.S. Miller, and S.D. Wright. 1996. 
 
J. Immunol.
 
 157:5589–5596). To examine fur-
ther the connection between intracellular transport of LPS and signaling, we observed internal-
ization of fluorescently labeled LPS in cells from LPS-hyporesponsive (
 
Lps
 
d
 
) mice. Binding of
fluorescent LPS from LPS–soluble CD14 (sCD14) complexes by peritoneal macrophages from
 
Lps
 
d
 
 and control (
 
Lps
 
n
 
) mice was quantitatively similar, and confocal images obtained from
these cells exhibited an identical appearance immediately after labeling. Incubation of labeled
 
Lps
 
n
 
 macrophages at 37
 
 
 
C caused movement of the fluorescence from the cell perimeter in one
or two spots in the perinuclear region. However, in 
 
Lps
 
d
 
 cells the fluorescence remained dis-
persed, suggesting a defect in vesicular transport. LPS resembles ceramide, and 
 
Lps
 
d
 
 mice fail to
respond to ceramide. As with LPS, we found that binding of fluorescent ceramide by 
 
Lps
 
d
 
 and
 
Lps
 
n
 
 macrophages was quantitatively similar, and the label moved rapidly to one to two spots in
the perinuclear region in 
 
Lps
 
n
 
 mice. However, in 
 
Lps
 
d
 
 macrophages the fluorescence remained
dispersed. These results show that cells deficient in responses to LPS exhibit defective vesicular
transport of LPS and ceramide and point to a role for vesicular transport in responses to these
mediators.
 
L
 
PS is transported to cell membranes by the action of
LPS-binding protein (LBP)
 
1
 
 and CD14. LBP acts to
transfer LPS monomers out of LPS aggregates to a binding
site on CD14, and LPS–soluble CD14 (sCD14) complexes
then deliver LPS to cells (1, 2). Because sCD14 is mono-
meric and binds LPS with low stoichiometry (1–2 LPS per
sCD14, reference 1), LPS–sCD14 complexes deliver mono-
meric LPS to cells, and these complexes have been shown
to stimulate cellular responses without a further require-
ment for LBP (3).
We have recently shown (4) that fluorescent LPS pre-
sented to PMN as LPS–sCD14 complexes appears first in
the plasma membrane, but that it is rapidly endocytosed
and accumulates in a perinuclear site. This intracellular ac-
cumulation is evident at 10–20 min and has a time course
coincident with the first cellular responses to LPS, integrin-
mediated adhesion. A potential role for vesicular trafficking
in signal transduction was suggested by the observation that
maneuvers that block endosomal fusion (lowering tempera-
ture to 19
 
 
 
C or addition of wortmannin) block the adhe-
sion response to LPS. These treatments do not block the
response to agonists such as formyl peptides that ligate ser-
pentine receptors and signal through heterotrimeric G pro-
teins.
To examine further a potential link between intracellular
transport of LPS and signaling, we have observed LPS up-
take in cells from mice with the LPS-hyporesponsive (
 
Lps
 
d
 
)
trait. Animals with this defect (C3H/HeJ, C57BL/10ScCR,
C57BL/10ScN) (5–7) are up to 1,000-fold less responsive
to the lethal and cytokine-inducing effects of LPS (8, 9),
and macrophages from these animals show a similar defect
in vitro (10). Here, we show that macrophages from 
 
Lps
 
d
 
mice exhibit a defect in endocytic movement of fluorescent
LPS. We further show that these cells also express a defect
in transport of a related molecule, ceramide.
 
1
 
Abbreviations used in this paper:
 
 AOAH, acyloxyacyl hydrolase; BODIPY,
boron dipyrromethane; BODIPY–ceramide, BODIPY-labeled C5-cera-
mide; BODIPY–LPS, BODIPY-labeled LPS; DF-BSA, defatted BSA;
EGF, epidermal growth factor; ERK1, mitogen-activated protein kinase
1; ERK2, mitogen-activated protein kinase 2; HAP, Dulbecco’s PBS
with 0.5 U/ml aprotinin, 0.05% human serum albumin, 3 mM 
 
d
 
-glucose;
HSA, human serum albumin; JNK, c-Jun NH
 
2
 
-terminal kinase; LBP,
LPS-binding protein; 
 
Lps
 
d
 
, LPS hyporesponsive; 
 
Lps
 
n
 
, LPS responsive;
PI3K, phosphatidylinositol 3-kinase; sCD14, soluble CD14.
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Materials and Methods
 
Reagents.
 
Aprotinin, Dulbecco’s PBS, and defatted BSA (DF-
BSA) were purchased from Sigma Chemical Co. (St. Louis, MO).
Pyrogen-free human serum albumin (HSA) was obtained from
Centeon, Armour, and Berring Pharmaceutical Co. (Kankakee, IL).
Unlabeled 
 
Salmonella minnesota
 
 Re595 LPS was purchased from List
Biologicals (Campbell, CA), and the fluoroprobe, boron dipyr-
romethane (BODIPY–FL) (Molecular Probes, Eugene, OR) was
conjugated to the LPS micelles as described (11). The ratio of
BODIPY to LPS molecules was estimated at 1:5. BODIPY–BSA
was purchased from Molecular Probes. Recombinant sCD14 was
provided by Dr. R. Thieringer (Merck Research Laboratories,
Rahway, NJ).
Complexes of BODIPY–LPS and sCD14 were prepared by
incubating BODIPY–LPS (10 ng/ml) with sCD14 (200 ng/ml)
overnight at 37
 
 
 
C as described (3). BODIPY–C5-ceramide was
obtained from Molecular Probes. A 1:1 complex of BODIPY–
C5-ceramide with DF-BSA was prepared as described (12). The
complex was 5 
 
 
 
M and was prepared in acid-buffered Eagle’s
MEM, pH 7.4, without color indicator.
The polyclonal anti-CD14 was provided by Dr. P.A. Detmers
(Merck Research Laboratories, Rahway, NJ), who produced and
purified it as described (13).
 
Macrophage Isolation and Culture Conditions. Lps
 
d
 
 mice, C57BL/
10ScN or C3H/HeJ, were obtained from Dr. S.K. Chapes (Kan-
sas State University, Manhattan, KS) or from Jackson Laboratories
(Bar Harbor, ME), respectively. LPS-responsive (
 
Lps
 
n
 
) mice,
C57BL/6J and C3H/HeN, were obtained from Jackson Labora-
tories and from Charles River Laboratories (Wilmington, MA),
respectively. C3H/HeJ and C57BL/10ScCR mice express a sim-
ilar defect, because both strains exhibit resistance to LPS (5, 7, 9),
in both strains the defect behaves as a Mendelian trait that maps to
chromosome 4 (7, 14), and crossing C3H/HeJ and C57BL/
10ScCR mice showed that the defects in these two strains do not
complement one another. The C57BL/10ScCR strain is a deriv-
ative of the C57BL/10ScN. Peritoneal macrophages were ob-
tained as previously described (15), and were used immediately in
experiments or were cultured overnight in teflon beakers in
RPMI-1640 without red phenol (GIBCO BRL, Gaithersburg, MD)
supplemented with 50 U/ml penicillin, 50 
 
 
 
g/ml streptomycin,
and 10% FCS. C57BL/10ScN and C57BL/6J mice were used for
flow cytometry experiments, and all four strains of mice were
tested by confocal microscopy.
 
Flow Cytometry.
 
Peritoneal macrophages were washed in
HAP buffer (Dulbecco’s PBS with 0.5 U/ml aprotinin, 0.05%
HSA, 3 mM 
 
d
 
-glucose) and incubated with BODIPY–ceramide–
BSA complexes (0.5 
 
 
 
M) or with BODIPY–LPS–sCD14 com-
plexes (20 ng/ml of LPS) for various times before analysis by flow
cytometry performed on a FACScan
 

 
 (Becton-Dickinson, Moun-
tain View, CA). 10,000 events were acquired per sample and the
results were analyzed on gated macrophages. The control for back-
ground fluorescence was cells incubated without BODIPY–LPS–
sCD14 or without BODIPY–ceramide–BSA complexes.
 
Confocal Scanning Laser Microscopy.
 
Cells were washed in HAP
buffer and exposed to BODIPY–LPS–sCD14 or BODIPY–cera-
mide–BSA complexes for 10 min at 37
 
 
 
C or 4
 
 
 
C, respectively, as
described in the text. Cells were then washed in HAP buffer and
warmed at 37
 
 
 
C for different times. Confocal scanning laser mi-
croscopy was then performed using a Nikon microscope equipped
with a 
 
 
 
100 objective (NA 1.4) and Bio-Rad MRC 600 instru-
mentation (Hercules, CA). Filters provided excitation at 488 nm.
Individual optical sections were collected digitally. The images
were collected and analyzed through the software (Comos) of the
confocal microscope (Bio-Rad). The figures display 1-
 
 
 
m optical
sections taken approximately at the midpoint of the cells.
 
Results
 
Lps
 
d
 
 and Lps
 
n
 
 Macrophages Show Equivalent Uptake of LPS
from LPS–sCD14 Complexes.
 
Upon exposure of mono-
cytes to BODIPY–LPS–sCD14 complexes for 10 min, the
mean fluorescence intensity rose equivalently for cells from
Figure 1. Staining of peritoneal macrophages by BODIPY–LPS–sCD14 complexes. Suspensions of peritoneal macrophages from Lpsn mice, C57BL/6J
strain, (A) or from Lpsd mice, C57BL/10ScN strain (B), were incubated for 10 min at 37 C with BODIPY–LPS–sCD14 complexes (20 ng/ml of LPS).
Cells were then washed, resuspended in buffer, warmed for 0 or 30 min at 37 C, then analyzed by flow cytometry. The cells incubated with BODIPY–
LPS–sCD14, washed, and warmed for 0 min at 37 C (heavy broken line) exhibited an increase of fluorescence as compared with the unstained cells (solid
line). Upon additional warming for 30 min at 37 C (light broken line), the mean fluorescence did not change. A similar pattern of fluorescence was ob-
served with peritoneal macrophages of both Lpsn and Lpsd mice. This experiment is a representation of three repeats. 
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Lps
 
d
 
 and 
 
Lps
 
n
 
 mice (Fig. 1). Uptake by these two strains
also showed similar kinetics because labeling was equiva-
lent, but about twofold lower, in cells incubated for only
5 min (data not shown). Cells labeled for 10 min were then
washed and warmed for 30 min at 37
 
 
 
C. This incubation
caused no alteration in fluorescence (Fig. 1, 
 
A
 
 and 
 
B
 
).
These results indicate that peritoneal macrophages from 
 
Lps
 
d
 
and 
 
Lps
 
n
 
 mice bind a similar amount of BODIPY–LPS and
that cell association of the fluorescent lipid is stable at 37
 
 
 
C.
To confirm the specificity of this binding, cells were first
incubated in the presence of a polyclonal anti-CD14 anti-
body at 4
 
 
 
C. Cells were then washed and incubated with
BODIPY–LPS–sCD14 for 10 min at 37
 
 
 
C. Under these
conditions, binding of LPS to macrophages was strongly
inhibited (80% inhibition; data not shown), which sug-
gested that mCD14 is required for LPS uptake. This result
was expected because both 
 
Lps
 
d
 
 and 
 
Lps
 
n
 
 mice express the
mCD14 protein on the surface of their macrophages and
because responses to LPS–sCD14 complexes (3) and uptake
of LPS from LPS–sCD14 complexes (Vasselon, T., R.
Pironkova, and P.A. Detmers, manuscript submitted for
publication) are both strongly dependent on mCD14. Ad-
ditional studies showed that the interaction of LPS with
cells was temperature sensitive. When cells were incubated
with BODIPY–LPS–sCD14 for 10 min at reduced tem-
peratures, the uptake of BODIPY–LPS was reduced 52% at
19
 
 
 
C and 91% at 4
 
 
 
C (data not shown).
 
Lps
 
d
 
 Macrophages Exhibit a Defect in Intracellular Transport of
LPS.
 
Immediately after labeling with BODIPY–LPS–
sCD14 complexes for 10 min at 37
 
 
 
C, confocal images of
cells from 
 
Lps
 
n
 
 and 
 
Lps
 
d
 
 mice exhibited an identical appear-
ance, with fluorescent LPS restricted to the cell perimeter
(0-min images; Fig. 2). Further incubation at 37
 
 
 
C of
washed, labeled 
 
Lps
 
n
 
 macrophages caused movement of the
fluorescence into one or two well-defined spots in the
perinuclear region. This movement was complete by 20
min and closely resembled the behavior we have previously
reported for PMN (4). In contrast, 
 
Lps
 
d
 
 macrophages did
not exhibit this movement of LPS. Rather, the fluores-
cence remained at the cell periphery at the 0- and 10-min
timepoints, and showed a dispersed, punctate appearance
even after 30 min of warming. To confirm the findings, we
recorded the appearance of a large number of cells. At the
20-min timepoint, 85% (
 
n
 
 
 
 
 
 512) of 
 
Lps
 
n
 
 control cells
showed the concentrated, perinuclear pattern of fluores-
cence, while only 4% (
 
n
 
 
 
 
 
 518) of 
 
Lps
 
d
 
 cells showed this
pattern. These observations suggest a defect in vesicular
transport in 
 
Lps
 
d
 
 cells.
 
Lps
 
d
 
 Macrophages Exhibit a Defect in Intracellular Transport of
BODIPY–Ceramide.
 
Ceramide is produced in cells in re-
sponse to TNF, and several lines of evidence suggest that
ceramide is an important intracellular second messenger
(16). For example, exogenously added ceramide induces
cytokine synthesis in murine macrophages (17). We have
shown that ceramide bears a striking structural resemblance
to the lipid A region of LPS (18) and have suggested that
ceramide and LPS may thereby provoke similar cellular re-
sponses. This possibility was strengthened by the recent
finding of Barber et al. (17) that 
 
Lps
 
d
 
 mice failed to respond
to ceramide. Thus, it is clear that the defect in 
 
Lps
 
d
 
 mice
interrupts signaling from both ceramide and LPS.
To determine whether 
 
Lps
 
d
 
 mice also express a defect in
the binding or transport of ceramide, we measured the up-
take and subcellular distribution of a fluorescent derivative
of ceramide (BODIPY–ceramide). As with BODIPY–LPS,
the BODIPY–ceramide was presented to cells as a mono-
meric complex with a protein (BSA). The kinetics of bind-
ing of BODIPY–ceramide–BSA complexes to peritoneal
macrophages of both strains was first assessed by flow cy-
tometry. Upon incubation at 4
 
 
 
C, the mean fluorescence
intensity was found to increase as a function of time. A
slight difference was observed at early timepoints, with 
 
Lps
 
d
 
cells showing slower uptake than 
 
Lps
 
n
 
 cells (data not shown).
However, the mean fluorescence intensity of peritoneal
macrophages from either 
 
Lps
 
n
 
 or 
 
Lpsd mice incubated with
BODIPY–ceramide–BSA shared a quantitatively similar
shift at the 30-min timepoint (Fig. 3, A and B). After the
staining, cells were washed and warmed at 37 C for 10
min. During warming, no change of the mean fluorescence
Figure 2. Subcellular distribution of BODIPY–LPS in Lpsd and Lpsn
macrophages. Cells were labeled with BODIPY–LPS–sCD14 complexes
for 10 min at 37 C, washed, and then warmed to 37 C. At the indicated
times, aliquots of cells were analyzed by scanning confocal microscopy.
This figure shows representative microoptical sections of Lpsn (left column)
and Lpsd (right column) cells and is representative of five repetitions. This
figure shows cells from C57BL/10ScN and control C57BL/6J mice, and
identical results were obtained with the Lpsd defect on a different back-
ground (C3H/HeJ versus C3H/HeN).2098 Defective Endocytic Uptake of LPS in Lpsd Mice
intensity was observed as compared with the 0-min time-
point (Fig. 3, A and B). These observations indicate that a
similar amount of fluorescent lipid associates with the
membranes of the Lpsd and Lpsn cells, and the association is
stable. As a control, binding of BODIPY–BSA was found
to be undetectable at the surface of both strains of mac-
rophages under the same conditions (data not shown).
Immediately after labeling with BODIPY–ceramide, con-
focal images of cells from Lpsn and Lpsd mice exhibited an
identical appearance, with fluorescent ceramide restricted
to the cell perimeter (0-min images; Fig. 4). These images
were similar to those of cells labeled with BODIPY–LPS
(see Fig. 2). Incubation of Lpsn macrophages at 37 C caused
rapid movement of the fluorescence to one or two well-
defined spots in the perinuclear region. This movement
closely resembled that of BODIPY–LPS but occurred at a
faster rate, being complete within 2 min. In contrast, Lpsd
macrophages did not exhibit this rapid movement of BO-
DIPY–ceramide. Label remained dispersed and did not col-
lect into the perinuclear area even after 10 min (Fig. 4).
This defect in Lpsd cells appeared to be one of kinetics be-
cause perinuclear accumulation of BODIPY–ceramide was
observed after longer incubation (30 min; data not shown).
In five repeats, 82% (n   505) of Lpsn cells at the 5-min
timepoint showed a concentration of fluorescence in the
perinuclear region, while only 8% (n   517) of Lpsd cells
showed this pattern. These observations suggest a defect in
vesicular transport in Lpsd cells that affects not only LPS but
also the structurally related molecule, ceramide.
Discussion
Rapid intracellular transport of fluorescent derivatives of
ceramide has been observed and extensively characterized
Figure 3. Staining of peritoneal macrophages by BODIPY–ceramide–BSA complexes. Peritoneal macrophages from Lpsn mice, C57BL/6J strain (A)
or from Lpsd mice, C57BL/10ScN strain (B) were incubated for 30 min at 4 C with BODIPY–ceramide–BSA complexes (0.5  M). Cells were then
washed, resuspended in buffer, warmed for 0 to 10 min at 37 C, and fluorescence was analyzed by FACScan. Incubation with fluorescent complexes of
BODIPY–ceramide–BSA resulted in strong staining (heavy broken line) that was not diminished upon 10 min of warming of the cells at 37 C (light broken
line) as compared with the unstained cells (solid line). A similar pattern of fluorescence was observed with peritoneal macrophages of both Lpsn and Lpsd
mice. This experiment is a representation of three repeats.
Figure 4. Subcellular distribution of BODIPY–ceramide in Lpsd and Lpsn
macrophages. Cultured peritoneal macrophages from Lpsn and Lpsd mice
were labeled with BODIPY–ceramide–BSA complexes (0.5  M) for 30 min
at 4 C, washed, and then warmed for the indicated times at 37 C. Shown
are optical sections of Lpsn (left column) and Lpsd (right column) cells and is
representative of five repetitions. This figure shows cells from C57BL/10ScN
and control C57BL/6J mice, and identical results were obtained with the
Lpsd defect on a different background (C3H/HeJ versus C3H/HeN).2099 Thiéblemont and Wright
by Pagano and others (19–22). Ceramide delivered to the
plasma membrane from ceramide–BSA conjugates accu-
mulates rapidly in the Golgi, and fluorescent ceramide has
been proposed as a vital stain for the Golgi (20). The simi-
larity of the images of cells stained with BODIPY–cera-
mide and BODIPY–LPS suggest that LPS may also be
transported to the Golgi, but further experiments are re-
quired to confirm this assignment. We have recently
pointed out the strong physical resemblance of ceramide
and LPS (18, 23), and the similar handling of these mole-
cules by macrophages is evidence that this resemblance may
have biological consequences.
After transport to the Golgi, ceramide is metabolized to
sphingomyelin, glucosyl ceramide, and further glycosphin-
golipid products (21, 22). The specific concentration of cera-
mide in the Golgi may thus reflect the workings of a dedi-
cated metabolic pathway. Our results suggest that the Lpsd
mutation is associated with a defect in vesicular transport
and that the defect bears on a pathway used for the trans-
port of sphingolipids. Several previous studies are consistent
with this interpretation. While Lpsn and Lpsd macrophages
have a similar content of gangliosides (24, 25), their distri-
bution is altered in Lpsd cells. Two species of ganglioside
could not be detected at the cell surface of Lpsd, while they
were readily detected on the surface of Lpsn cells (24–26).
LPS is known to be deacylated by a specialized enzyme
(AOAH) restricted to a low density intracellular compart-
ment in PMN (27). Though macrophages from Lpsd and
Lpsn mice have similar amounts of this enzyme and bind
similar amounts of LPS, Munford et al. (28) showed that
deacylation after 20 h of incubation was lower in Lpsd mac-
rophages than in Lpsn macrophages. Finally, the observa-
tion that Lpsd macrophages fail to respond to ceramide
strongly suggests that Lpsd cells show alterations in their re-
sponses to sphingolipids.
The above results demonstrate a strong correlation be-
tween cell signaling and LPS internalization. This correlation
may arise because traffic of internalized membrane is neces-
sary for signaling or because signaling is necessary for the
membrane traffic observed here. Several considerations
make us favor the view that membrane traffic or internal-
ization is necessary for signaling. First, BODIPY–ceramide
does not cause TNF secretion at the concentrations used
here (our unpublished observations), and its rapid internal-
ization (Fig. 4) thus appears to occur in the absence of sig-
naling. Second, our previous work showed that cytochala-
sin D, wortmannin, or low temperatures all caused profound
blockade of cellular responses to LPS and to TNF but not
to other stimuli (4). These agents are all known to block
vesicular traffic. Additional recent work is also consistent
with a role for vesicular transport in certain types of signal-
ing. Exposure of cells to osmotic stress or UV light results
in activation of the c-Jun NH2-terminal protein kinase cas-
cade. This response is accompanied by clustering and inter-
nalization of cell surface TNF receptors, and lowering the
temperature to 15 C blocks both internalization of TNFR
and signaling (29). Other recent studies show that blockade
of endocytosis of EGF receptors by expression of mutant
dynamin causes inhibition of EGF-dependent phosphoryla-
tion of ERK1, ERK2, and PI3K (30). Nevertheless, at this
time we cannot rule out the possibility that signaling plays a
role in the redistribution of LPS and ceramide observed here.
Studies are underway to clarify further the relationship be-
tween signaling and vesicular traffic in responses to LPS.
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